Found 187 results in Expert Content

Summary: A recent survey explored the attitudes and changing perceptions of experienced Phase 1 development professionals toward development challenges and available solutions.

Summary: Mike Riley, President, Catalent Biologics, will discuss the latest trends in ADC discovery and development, with a focus on how next generation pipelines are being shaped by payload and linker chemistry innovations, including those from Catalent’s award-winning SMARTag® ADC platform.

Summary: In this eBook, learn more about how the timely progression of a drug candidate into clinical trials is critical for pharmaceutical companies seeking to bring new products to the market.

In this webinar experts will discuss the challenges cell and gene therapy innovators face and how experts resolve these barriers through adopting technology and strategy that drive an optimized plasmid production process and supply.

In this webinar experts will discuss a unique approach that integrates advanced formulation expertise with on-demand Phase 1 clinical manufacturing, adaptive clinical testing, statistical and regulatory support to help achieve flexible and efficient First-in-Human studies and fast development for challenging molecules.

In this webinar, experts review the definition of integrated solutions in the pharmaceutical industry, discuss the benefit and challenges of these integrated approaches and provide insights on whether integrated solutions can be the key to achieving development milestones.

In this webinar, experts will discuss a unique approach that integrates advanced formulation expertise with on-demand phase I clinical manufacturing, adaptive clinical testing, and regulatory support.

Read this case study to learn more about Catalent's partnership with Clarus to develop a unique and convenient drug delivery form for their hormone replacement therapy.

Summary: Experts discuss integrated solutions in the pharmaceutical industry and the benefits and challenges of this approach. Is this the key to more aggressive development milestones?

Summary: Listen in as Mike and Darren share how new modalities and manufacturing technologies have altered the partnership landscape between developers and CDMOs.